Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Field Alert Reports (FAR-USFDA); Europe Rapid Alerts ; Europe Informing National Competent Authority (NCA)
Qvents
1 minute read
Uncategorized
Home
Guidelines
Field Alert Reports (FAR-USFDA); Europe Rapid Alerts ; Europe Informing National Competent Authority (NCA)
Updated on October 11, 2023
Home
Guidelines
Field Alert Reports (FAR-USFDA); Europe Rapid Alerts ; Europe Informing National Competent Authority (NCA)
Updated on October 11, 2023
USFDA
Field Alert Reports
;
USFDA
Field Alert Report Submission: Questions and Answers Guidance for Industry
;
Guidance
USFDAÂ
Field Alert Report Form:
Questions and Answers
USFDA
Field Alert Report (FAR) regulations: NDA:
21 CFR 314.81(b)(1)
; ANDAs:
21 CFR 314.98
Europe: Informing National Competent Authority (NCA)
,
Dealing with Quality Defects and Rapid Alerts Rapid Alerts
; Presentation by David Cockburn, Head of Manufacturing and Quality Compliance European Medicines Agency
Europe
Quality Defects and Recall (EMA):
Reporting of Product quality defect, including a suspected defect, of a centrally authorised medicine which could result in a recall or abnormal restriction on supply to the European Medicines Agency (EMA)
Reporting a quality defect to EMA
(
Europe
)
PIC/S
Procedure For Handling Rapid Alerts And Recalls Arising From Quality Defects
(Europe)
CDSCO (India)
:
Guidelines On Recall And Rapid Alert System For Drugs
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA 483 Cites Piramal Pharma for Investigation Deficiencies, Procedural Non-Compliance
March 13, 2025
Contamination Control and Data Integrity Issues: Granules India Receives USFDA Warning Letter
March 7, 2025
Janssen’s Korea Vaccine Unit USFDA 483 Cites Aseptic Operations Not in Control
February 26, 2025
Facility Registration Violations, Refusal of Inspection: Jagsonpal Issued Warning letter
February 22, 2025
Purified Water System Qualification and Control: USFDA Expectations
February 11, 2025